Uploaded on Apr 15, 2024
According to the latest research report by IMARC Group, The global needle-free drug delivery technology market size reached US$ 4.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.7 Billion by 2032, exhibiting a growth rate (CAGR) of 4.56% during 2024-2032. More Info:- https://www.imarcgroup.com/needle-free-drug-delivery-technology-market
Needle-free Drug Delivery Technology Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
Global Needle-free Drug
Delivery Technology
Market Research and
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved
About IMARC Group
In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management
s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry
vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and
t ransform thei r bus inesses.
IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological
developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology
organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls ,
chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods
are at the top of the company’s exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and
markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients
achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure
las t ing resul ts .
A cc o r d i ng t o t h e l a te s t r e p o r t b y I MA R C Gr o u p , t i t l e d " N e e d l e - f r e e D r u g D e l i v e r y
T ec h n o l o g y Ma r k e t : G l o b a l I n d u s t r y T r e n d s , S h a re , S i z e , G r o wt h , O p p o r t u n i ty a n d
F o r e c a s t 2 0 24 - 2 0 32 , " t h e g l ob a l n e e d l e - f r e e d r ug d e l i v e r y t ec h n o l o gy ma r k e t s i z e
r ea c h e d U S $ 4 . 4 B i l l i on i n 2 0 2 3 .
N ee d l e - f re e d r u g de l i v e r y t e c h no l o g y i s a m e d i c a l i n n ov a t i o n t h a t a l l o w s f o r
Report ad m i n i s t e r i n g m ed i c a t i o ns w i t h ou t u s i n g t r a d i t i on a l h y p od e r m i c n e ed l e s . I t i s de s i g n e d
t o i m p ro v e t h e p a t i e n t ' s ex p e r i en c e by e l i m i n a t i n g t h e p a i n a n d an x i e t y a ss oc i a t ed w i t h
ne e d l e - ba s e d i n j e c t i on s . M o r eo v e r , i t a i m s t o re d u c e t he r i s k s o f n e e d l e - s t i c k i n j u r i e s
Highlight and an d c r os s - c on t a m i n a t i o n , w h i c h a re s i g n i f i c a n t c o n c e r n s i n he a l t h ca r e s e t t i n g s .
T he t e c h n o l o g y e m p l oy s v a r i o us me t h o ds t o i n t r o d u ce m e d i c a t i o n s i n to t h e b od y , s u c h
Description as j e t i n j e c t i o n , w h i c h u se s h i g h p r e ss u r e t o p ro p e l a f i n e s t r e a m o f m ed i c i n e th r o u g h t he s k i n a nd i n t o t he u n d e r l y i n g t i s su e . N e ed l e - f r ee d r u g de l i v e r y i s p a r t i c u l a r l y
be n e f i c i a l f o r c h i l d r e n , g e r i a t r i c p o p u l a t i o n , a n d pa t i e n t s f e a r i n g n e ed l e s . I t i s a l s o
va l u a b l e i n m a s s v ac c i n a t i on c a mp a i g n s w h e r e q u i c k a n d e f f i c i e n t de l i v e r y o f v a c c i ne s
i s es s e n t i a l .
R eq u e s t f o r a P D F sa m p le o f th i s r ep o r t :
h t t p s : / /w w w . i ma r c g r o u p . co m / n ee d l e - f r e e - d ru g - d e l i ve r y - t ec h n o l o gy - m ar k e t / re q u e s t s a m p l
e
Report Description
G lo b a l N e e d le - f r e e D r u g D e l i v e r y Te c h n o l o g y M a r k e t T r e n d s :
T h e i n c r e a s i n g p r e v a l e n c e o f c h r o n i c d i s e a s e s , s u c h a s d i a b e t e s a n d c a r d i o v a s c u l a r c o n d i t i o n s n e c e s s i t a t i n g f r e q u e n t m e d i c a t i o n
a d m i n i s t r a t i o n i s o n e o f t h e m a j o r f a c t o r s c o n t r i b u t i n g t o t h e m a r k e t g r o w t h . N e e d l e - f r e e s y s t e m s o f f e r a m o r e c o m f o r t a b l e a n d l e s s
i n v a s i v e a l t e r n a t i v e f o r p a t i e n t s w h o r e q u i r e r e g u l a r i n j e c t i o n s . I n a d d i t i o n t o t h i s , t h e w i d e s p r e a d u t i l i z a t i o n o f n e e d l e - f r e e d r u g d e l i v e r y
t e c h n o l o g y a s i t a d d r e s s e s c r i t i c a l s a f e t y c o n c e r n s i n h e a l t h c a r e a n d e n h a n c e s o c c u p a t i o n a l s a f e t y i s p r o v i d i n g a t h r u s t t o t h e m a r k e t
g r o w t h . T r a d i t i o n a l n e e d l e - b a s e d s y s t e m s p o s e t h e r i s k o f n e e d l e - s t i c k i n j u r i e s , w h i c h c a n l e a d t o t h e t r a n s m i s s i o n o f i n f e c t i o u s d i s e a s e s
a m o n g h e a l t h c a r e w o r k e r s a n d p a t i e n t s . A l o n g w i t h t h i s , t h e g r o w i n g p o p u l a r i t y o f t h i s t e c h n o l o g y , a s i t o f f e r s i m p r o v e d p a t i e n t
e x p e r i e n c e , e s p e c i a l l y i n t h e p e d i a t r i c a n d g e r i a t r i c p o p u l a t i o n , l e a d i n g t o b e t t e r c o m p l i a n c e w i t h t r e a t m e n t r e g i m e n s , i s c r e a t i n g a
p o s i t i v e o u t l o o k f o r t h e m a r k e t g r o w t h . M o r e o v e r , t h e i n c r e a s i n g a p p l i c a b i l i t y o f n e e d l e - f r e e s y s t e m s i n m a s s i m m u n i z a t i o n p r o g r a m s ,
e n a b l i n g f a s t e r d e l i v e r y , w h i c h i s p a r t i c u l a r l y b e n e f i c i a l i n u r g e n t p u b l i c h e a l t h s i t u a t i o n s , s u c h a s p a n d e m i c s o r o u t b r e a k s , i s p r o v i d i n g
a n i m p e t u s t o t h e m a r k e t g r o w t h . F u r t h e r m o r e , t h e i n c r e a s i n g r e g u l a t o r y s u p p o r t a s g o v e r n m e n t s a n d h e a l t h c a r e o r g a n i z a t i o n s
i n c r e a s i n g l y r e c o g n i z e t h e b e n e f i t s o f n e e d l e - f r e e d r u g d e l i v e r y m e t h o d s b y a l l o c a t i n g g r a n t s a n d f u n d i n g f o r r e s e a r c h a n d d e v e l o p m e n t
( R & D ) , t h e r e b y f a c i l i t a t i n g i n n o v a t i o n a n d c o m m e r c i a l i z a t i o n , i s s u p p o r t i n g t h e m a r k e t g r o w t h .
L o o k in g f o r w a r d , t h e m a r k e t v a lu e i s p r o j e c t e d t o r e a c h U S $ 6 . 7 B i l l i o n b y 2 0 3 2 , e x p a n d i n g a t a C A G R o f 4 . 5 6 % d u r in g
2 0 2 4 - 2 0 3 2 .
V ie w R e p o r t T O C , F i g u r e s a n d T a b l e s : h t t p s : / / w w w . i m a r c g r o u p . c o m / n e e d l e - f r e e - d r u g - d e l i v e r y - t e c h n o l o g y - m a r k e t
Product Insights:
• Inhaler
• Jet Injector
• Novel Needles
• Transdermal Patch
• Others
Report
Application Insights:
Segmentation • Vaccine Delivery
• Pain Management
• Insul in Del ivery
• Others
End User Insights:
• Hospitals and Cl inics
• Homecare Sett ings
• Research Laboratories
• Academics
• Others
Regional Insights:
Report
• North America
Segmentation • Europe
• Asia-Pacifi c
• Latin America
• Middle East and Afr ica
• Akra Dermojet
• Antares Pharma Inc. (Halozyme
Therapeutics Inc.)
• Crossject
Competitive
• Mika Medical Co.
Landscape • PharmaJet
with Key • Portal Instruments Inc.
Players
How big is the global needle-free drug delivery
technology market?
What is the expected growth rate of the global needle-
free drug delivery technology market during 2024-
2032?
Key
What are the key factors driving the global needle-free
Questions drug delivery technology market?
Answered in
What has been the impact of COVID-19 on the global
needle-free drug delivery technology market?
the Report
What are the key regions in the global needle-free drug
delivery technology market?
Who are the key players/companies in the global
needle-free drug delivery technology market?
1 P r e f a c e
2 S c o p e a n d M e t h o d o l o g y
2 . 1 O b j e c t i v e s o f t h e S t u d y
2 . 2 S t a k e h o l d e r s
2 . 3 D a t a S o u r c e s
2 . 3 . 1 P r i m a r y S o u r c e s
2 . 3 . 2 S e c o n d a r y S o u r c e s
2 . 4 M a r k e t E s t i m a t i o n
Table of 2 . 4 . 1 B o t t o m - U p A p p r o a c h 2 . 4 . 2 T o p - D o w n A p p r o a c h
2 . 5 F o r e c a s t i n g M e t h o d o l o g y
3 E x e c u t i v e S u m m a r y
4 I n t r o d u c t i o n
Contents 4 . 1 O v e r v i e w 4 . 2 K e y I n d u s t r y T r e n d s5 G l o b a l N e e d l e - f r e e D r u g D e l i v e r y T e c h n o l o g y M a r k e t
5 . 1 M a r k e t O v e r v i e w
5 . 2 M a r k e t P e r f o r m a n c e
5 . 3 I m p a c t o f C O V I D - 1 9
5 . 4 M a r k e t F o r e c a s t
6 M a r k e t B r e a k u p b y P r o d u c t
6 . 1 I n h a l e r
6 . 1 . 1 M a r k e t T r e n d s
6 . 1 . 2 M a r k e t F o r e c a s t
6 . 2 J e t I n j e c t o r
6 . 2 . 1 M a r k e t T r e n d s
6 . 2 . 2 M a r k e t F o r e c a s t
6 . 3 N o v e l N e e d l e s
6 . 3 . 1 M a r k e t T r e n d s
6 . 3 . 2 M a r k e t F o r e c a s t
6 . 4 T ra n s d e rm a l P a t c h
6 . 4 . 1 M a rk e t T re n d s
6 . 4 . 2 M a rk e t F o r e c a s t
6 . 5 O t h e rs
6 . 5 .1 M a rk e t T re n d s
6 . 5 .2 M a rk e t F o r e c a s t
7 M ar k e t B r e a k u p b y A p p l i c a t i o n
7 . 1 V a c c i n e D e l i v e r y
7 . 1 . 1 M a rk e t T re n d s
7 . 1 . 2 M a rk e t F o r e c a s t
7 . 2 P a i n M a na g e me n t
Table of 7 . 2 .1 M a rk e t T re n d s
7 . 2 .2 M a rk e t F o r e c a s t
7 . 3 I ns u l i n D e l i v e r y
Contents 7 . 3 .1 M a rk e t T re n d s 7 . 3 .2 M a rk e t F o r e c a s t
7 . 4 O t h e rs
7 . 4 .1 M a rk e t T re n d s
7 . 4 .2 M a rk e t F o r e c a s t
8 M ar k e t B r e a k u p b y E n d U s er s
8 . 1 H o s p i t a l s a n d C l i n i c s
8 . 1 .1 M a rk e t T re n d s
8 . 1 .2 M a rk e t F o r e c a s t
8 . 2 H o m e ca r e S e t t i n g s
8 . 2 .1 M a rk e t T re n d s
8 . 2 .2 M a rk e t F o r e c a s t
F o r m o r e i n f o r m a t i o n , v i s i t :
ht tps : / /www. imarcgroup .com/need le - f ree-d rug -de l ive ry - te
chno logy-market / toc
Disclaimer
© 2023 IMARC Al l R ights Reserved
Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f
I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be
rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so
no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing ,
reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress
c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) .
Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion
have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f
pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f
war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC
accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r
i naccu rac ies i f any f ound th is pub l i ca t ion .
IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l
Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re
reg i s te red t rademarks o f t he i r r espec t i ve compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: [email protected]
Comments